These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 25422226

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F, Li WM, Wang DM, Gao SS, Bao Y, Chen WB, Liu D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B, He YJ, Tian YX, Yang RN, Zhu YR, Qiu H.
    Asian Pac J Cancer Prev; 2014 Sep; 15(22):9611-4. PubMed ID: 25520076
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L, Xie XW, Wang HY, Ma LY, Wen ZG.
    Asian Pac J Cancer Prev; 2015 Sep; 16(12):4891-4. PubMed ID: 26163610
    [Abstract] [Full Text] [Related]

  • 10. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
    Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F.
    J Transl Med; 2019 Mar 08; 17(1):74. PubMed ID: 30849967
    [Abstract] [Full Text] [Related]

  • 11. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S, Shen L, Qian N, Chen K.
    Cancer Biomark; 2019 Mar 08; 10(3-4):155-62. PubMed ID: 22674301
    [Abstract] [Full Text] [Related]

  • 12. Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
    Yang-Chun F, Min F, Di Z, Yan-Chun H.
    Medicine (Baltimore); 2016 May 08; 95(18):e3568. PubMed ID: 27149479
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer.
    Wang L, Wang D, Zheng G, Yang Y, Du L, Dong Z, Zhang X, Wang C.
    Int J Biol Markers; 2016 Feb 28; 31(1):e80-7. PubMed ID: 26560853
    [Abstract] [Full Text] [Related]

  • 14. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
    Dong Y, Zheng X, Yang Z, Sun M, Zhang G, An X, Pan L, Zhang S.
    J Cancer Res Ther; 2016 Oct 28; 12(Supplement):34-36. PubMed ID: 27721249
    [Abstract] [Full Text] [Related]

  • 15. New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?
    Li M, Zhang Y, Jiang L, Li Y, Li G, Zhou J, Yang C, Li X, Qu W, Chen Y, Chen Q, Wang S, Xing J, Huang H.
    Neoplasma; 2022 May 28; 69(3):729-740. PubMed ID: 35471981
    [Abstract] [Full Text] [Related]

  • 16. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
    Bai Y, Shen W, Zhu M, Zhang L, Wei Y, Tang H, Zhao J.
    J Cell Biochem; 2019 Jan 28; 120(1):105-114. PubMed ID: 30216488
    [Abstract] [Full Text] [Related]

  • 17. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y, Wang Z, Ding Y, Sun F, Ding X.
    Asian Pac J Cancer Prev; 2019 Aug 01; 20(8):2405-2407. PubMed ID: 31450913
    [Abstract] [Full Text] [Related]

  • 18. Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1.
    Paone G, De Angelis G, Munno R, Pallotta G, Bigioni D, Saltini C, Bisetti A, Ameglio F.
    Eur Respir J; 1995 Jul 01; 8(7):1136-40. PubMed ID: 7589398
    [Abstract] [Full Text] [Related]

  • 19. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ, Tao Z, Gu W, Sun LH.
    Asian Pac J Cancer Prev; 2013 Jul 01; 14(7):4369-71. PubMed ID: 23992005
    [Abstract] [Full Text] [Related]

  • 20. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P, Li J.
    Zhongguo Fei Ai Za Zhi; 2016 Oct 20; 19(10):641-647. PubMed ID: 27760591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.